Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency

Journal of the American Geriatrics Society

Volumn 58, Issue 8, 2010, Pages 1489-1495

  Giusti, Andrea ^a   Barone, Antonella ^a   Pioli, Giulio ^b   Girasole, Giuseppe ^c   Razzano, Monica ^a   Pizzonia, Monica ^a   Pedrazzoni, Mario ^d   Palummeri, Ernesto ^a   Bianchi, Gerolamo ^c  

^a GALLIERA HOSPITAL   (Italy)

^b S MARIA NUOVA HOSPITAL   (Italy)

^c Ospedale La Colletta   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

25 hydroxy vitamin D; cholecalciferol; elderly; secondary hyperparathyroidism

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; BETA C TERMINAL TELOPEPTIDE OF TYPE 1 COLLAGEN; CALCIUM; COLECALCIFEROL; COLLAGEN; PARATHYROID HORMONE; PHOSPHATE; UNCLASSIFIED DRUG;

AGED; ARTICLE; BONE METABOLISM; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG DOSE COMPARISON; FEMALE; GENETIC HETEROGENEITY; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

AGED; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; CALCIUM; CHOLECALCIFEROL; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; PARATHYROID HORMONE; PEPTIDES; PHOSPHATES; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 77955242464     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02970.x     Document Type: Article

References (33)

1. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocrine Rev 2001 22 : 477 501.
2. Gallagher JC, Kinyamu HK, Fowler SE et al. Calciotropic hormones and bone markers in the elderly. J Bone Miner Res 1998 13 : 475 482.
3. Harris SS, Soteriades E, Framingham Heart Study; Boston Low-Income Elderly Osteoporosis Study, et al. Secondary hyperparathyroidism and bone turnover in elderly blacks and whites. J Clin Endocrinol Metab 2001 86 : 3801 3804.
4. Giusti A, Barone A, Razzano M et al. High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. J Endocrinol Invest 2006 29 : 809 813.
5. Chapuy MC, Schott AM, Garnero P et al. Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 1996 81 : 1129 1133.
6. Lips P, Duong T, Oleksik A et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from the Multiple Outcomes of Raloxifene Evaluation clinical trial. J Clin Endocrinol Metab 2001 86 : 1212 1221.
7. Bianchi G, Giusti A, Palummeri E et al. Hot topics from the 4th International Conference on Osteoporosis in Men. Int J Clin Rheumatol 2009 4 : 41 44.
8. Visser M, Deeg DJ, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003 88 : 5766 5772.
9. Sambrook PN, Chen JS, March LM et al. Serum parathyroid hormone predicts time to fall independent of vitamin D status in a frail elderly population. J Clin Endocrinol Metab 2004 89 : 1572 1576.
10. Sambrook PN, Chen JS, March LM et al. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin D status, bone mass and renal function in the frail and very old; a cohort study. J Clin Endocrinol Metab 2004 89 : 5477 5481.
11. Bacon CJ, Gamble GD, Horne AM et al. High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 2009 20 : 1407 1415.
12. Chel V, Wijnhoven HAH, Smit JH et al. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 2008 19 : 663 671.
13. Vieth R, Kimball S, Hu A et al. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J 2004 19 : 3 8.
14. Przybelski R, Agrawal S, Krueger D et al. Rapid correction of low vitamin D status in nursing home residents. Osteoporos Int 2008 19 : 1621 1628.
15. Bischoff-Ferrari HA, Giovannucci E, Willett WC et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006 84 : 18 28.
16. Premaor MO, Scalco R, da Silva MJ et al. The effect of a single dose versus a daily dose of cholecalciferol on the serum 25-hydroxycholecalciferol and parathyroid hormone levels in the elderly with secondary hyperparathyroidism living in a low-income housing unit. J Bone Miner Metab 2008 26 : 603 608.
17. Bischoff-Ferrari HA, Willett WC, Wong JB et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: A meta-analysis of randomized controlled trials. Arch Intern Med 2009 169 : 551 561.
18. Bischoff-Ferrari HA, Willett WC, Wong JB et al. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 2005 293 : 2257 2264.
19. Barone A, Giusti A, Pioli G et al. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: A randomized controlled trial. J Am Geriatr Soc 2007 55 : 752 757.
20. Barone A, Giusti A, Pioli G et al. Was it inappropriate to give osteoporosis patients calcitriol instead of vitamin D? Response letter to Dr. Vieth. J Am Geriatr Soc 2008 56 : 576 577.
21. Yendt ER, Kovacs KA, Jones G. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: Optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction. Clin Endocrinol (Oxf) 2008 69 : 855 863.
22. Dandona P, Mohiuddin J, Weerakoon JW et al. Persistence of parathyroid hypersecretion after vitamin D treatment in Asian vegetarians. J Clin Endocrinol Metab 1984 59 : 535 537.
23. Peacey SR, Wright D, Harries MJ. Failure to normalize parathyroid hormone during treatment of vitamin D deficiency in Asian patients. Clin Endocrinol (Oxf) 2004 61 : 603 606.
24. Aloia JF, Patel M, Dimaano R et al. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr 2008 87 : 1952 1958.
25. Cockcroft D, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 : 31 41.
26. Cook PF, Emiliozzi S, McCabe MM. Telephone counseling to improve osteoporosis treatment adherence: An effectiveness study in community practice settings. Am J Med Qual 2007 22 : 445 456.
27. Giusti A, Barone A, Razzano M et al. Persistence with calcium and vitamin D in elderly patients after hip fracture. J Bone Miner Metab 2009 27 : 95 100.
28. Seeman E, Compston J, Adachi J et al. Non-compliance: The Achilles' heel of anti-fracture efficacy. Osteoporos Int 2007 18 : 711 719.
29. Angbrat M, Moller M. Questionnaire about calcium intake: Can we trust the answers? Osteoporos Int 1999 9 : 220 225.
30. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006 116 : 2062 2072.
31. Heaney RP, Armas LA, Shary JR et al. 25-Hydroxylation of vitamin D3: Relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr 2008 87 : 1738 1742.
32. Ilahi M, Armas LA, Heaney RP. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 2008 87 : 688 691.
33. Heaney RP. Barriers to optimizing vitamin D3 intake for the elderly. J Nutr 2006 136 : 1123 1125.